News

Featured News

  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • News | June 1, 2021

    Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases

    Read More

    News | May 18, 2021

    Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform

    Read More

    Press Release | March 31, 2021

    Entrada Therapeutics Announces Closing of $116 Million Series B Financing

    Read More

    Press Release | March 30, 2021

    Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics

    Read More

    Press Release | March 18, 2021

    Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates

    Read More

    News | March 18, 2021

    CAR-M era begins as Carisma doses first patient

    Read More

    News | January 8, 2021

    DiCE gets its ‘library’ card ready as it speeds development of DNA database-derived molecules with more investor cash

    Read More

    News | January 7, 2021

    CARISMA Therapeutics Completes Series B Funding to Advance Development of Novel CAR-Macrophage Immunotherapies

    Read More